We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Vision Therapy/Orthoptic on Motor & Sensory Status of the 3 to 7 Years Old Strabismic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00917982
Recruitment Status : Unknown
Verified June 2009 by Shahid Beheshti University of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : June 11, 2009
Last Update Posted : June 11, 2009
Sponsor:
Information provided by:
Shahid Beheshti University of Medical Sciences

Brief Summary:
Vision therapy (VTO) is a group of non-surgical treatment helping patients in 3 subjects;1)increasing the the visual acuity 2)improving the mechanical skills resulting in increasing the power of extraocular muscles,biocular vision,peripheral vision 3) increasing the perceptual skills making the brain to percept the colour and visual memory better.In this study we are going to compare the effect of vision therapy /orthoptic on motor & sensory of the 3 to 7 years old strabismic patients

Condition or disease Intervention/treatment Phase
Strabismus Other: vision therapy Phase 1

Study Type : Interventional  (Clinical Trial)
Official Title: The Effect of Vision Therapy/Orthoptic on Motor & Sensory Status of the 3 to 7


Arm Intervention/treatment
Vision therapy Other: vision therapy




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 7 Years   (Child)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • 3<age<7
  • Congenital isotropia

Exclusion Criteria:

  • Muscular disease
  • General ocular and systemic disease
  • Seizure
  • Visual Acuity < 60/20
  • Nystagmus
  • Follow up less than 3 months after surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00917982


Locations
Iran, Islamic Republic of
Ophthalmic Research Center Recruiting
Tehran, Iran, Islamic Republic of, 166666
Contact: zhaleh Rajavi, MD    +98 21 22585952    labbafi@hotmail.com   
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences

ClinicalTrials.gov Identifier: NCT00917982     History of Changes
Other Study ID Numbers: 8801
First Posted: June 11, 2009    Key Record Dates
Last Update Posted: June 11, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Strabismus
Ocular Motility Disorders
Cranial Nerve Diseases
Nervous System Diseases
Eye Diseases